Association of Therapy for Autoimmune Disease With Myelodysplastic Syndromes and Acute Myeloid Leukemia-Reference-Cited by-同舟云学术

Association of Therapy for Autoimmune Disease With Myelodysplastic Syndromes and Acute Myeloid Leukemia

Published:2017-07-01 Issue:7 Volume:3 Page:936
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Ertz-Archambault Natalie¹,Kosiorek Heidi²,Taylor Gretchen E.¹,Kelemen Katalin³,Dueck Amylou²,Castro Janna⁴,Marino Robert⁵,Gauthier Susanne⁵,Finn Laura⁶,Sproat Lisa Z.⁷,Palmer Jeanne⁷,Mesa Ruben A.⁷,Al-Kali Aref⁶,Foran James⁸,Tibes Raoul⁷

Affiliation:

1. Department of Internal Medicine, Mayo Clinic, Phoenix, Arizona

2. Division of Health Sciences Research, Section of Biostatistics, Mayo Clinic, Phoenix, Arizona

3. Department of Laboratory Medicine and Pathology, Mayo Clinic, Phoenix, Arizona

4. Department of Information Technology, Mayo Clinic, Phoenix, Arizona

5. Division of Planning and Practice Analysis, Mayo Clinic, Phoenix, Arizona

6. Department of Hematology and Oncology, Mayo Clinic, Rochester, Minnesota

7. Department of Hematology and Oncology, Mayo Clinic, Phoenix, Arizona

8. Department of Hematology and Oncology, Mayo Clinic, Jacksonville, Florida

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Cited by 93 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chronic myeloid leukemia in an ulcerative colitis patient receiving azathioprine: A case report;Int. Journal of Clinical Pharmacology and Therapeutics;2024-09-01

2. Updates in biology, classification, and management of acute myeloid leukemia with antecedent hematologic disorder and therapy related acute myeloid leukemia;Leukemia Research;2024-09

3. Myeloid neoplasms arising after methotrexate therapy for autoimmune rheumatological diseases do not exhibit poor-risk molecular features;Blood Cancer Journal;2024-07-19

4. The impact of cytotoxic therapy on the risk of progression and death in clonal cytopenia(s) of undetermined significance;Blood Advances;2024-06-13

5. Efficacy and safety of targeted therapies in VEXAS syndrome: retrospective study from the FRENVEX;Annals of the Rheumatic Diseases;2024-05-22